{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T12:40:18Z","timestamp":1793364018290,"version":"4.5.0"},"reference-count":247,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AG069333"],"award-info":[{"award-number":["AG069333"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AG079264"],"award-info":[{"award-number":["AG079264"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ageing Research Reviews"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.arr.2024.102291","type":"journal-article","created":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T21:40:08Z","timestamp":1712871608000},"page":"102291","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"special_numbering":"C","title":["Treating Alzheimer\u2019s disease using nanoparticle-mediated drug delivery strategies\/systems"],"prefix":"10.1016","volume":"97","author":[{"given":"Aryan Kia","family":"Roghani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo Isaiah","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Roghani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aananya","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachi","family":"Khemka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruhananhad P.","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasanthkumar","family":"Pattoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Jacob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Hemachandra","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ujala","family":"Sehar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arr.2024.102291_bib1","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/1357-4310(96)88720-X","article-title":"Transporting therapeutics across the blood-brain barrier","volume":"2","author":"Abbott","year":"1996","journal-title":"Mol. Med Today"},{"key":"10.1016\/j.arr.2024.102291_bib2","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrn1824","article-title":"Astrocyte-endothelial interactions at the blood-brain barrier","volume":"7","author":"Abbott","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.arr.2024.102291_bib3","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.nbd.2009.07.030","article-title":"Structure and function of the blood-brain barrier","volume":"37","author":"Abbott","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.arr.2024.102291_bib4","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.4334","article-title":"An in vitro blood-brain barrier model to study the penetration of nanoparticles","volume":"12","author":"Aday","year":"2022","journal-title":"Bio Protoc."},{"key":"10.1016\/j.arr.2024.102291_bib5","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.2174\/138161211797440186","article-title":"Breast cancer resistance protein and P-glycoprotein in brain cancer: two gatekeepers team up","volume":"17","author":"Agarwal","year":"2011","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.arr.2024.102291_bib6","doi-asserted-by":"crossref","first-page":"72","DOI":"10.4103\/2045-9912.311498","article-title":"A review on the neuroprotective effects of hyperbaric oxygen therapy","volume":"11","author":"Ahmadi","year":"2021","journal-title":"Med Gas. Res"},{"key":"10.1016\/j.arr.2024.102291_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev-bioeng-071811-150124","article-title":"The effect of nanoparticle size, shape, and surface chemistry on biological systems","volume":"14","author":"Albanese","year":"2012","journal-title":"Annu Rev. Biomed. Eng."},{"key":"10.1016\/j.arr.2024.102291_bib8","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.addr.2012.09.037","article-title":"Liposomal drug delivery systems: from concept to clinical applications","volume":"65","author":"Allen","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.arr.2024.102291_bib9","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nbt.1807","article-title":"Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes","volume":"29","author":"Alvarez-Erviti","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.arr.2024.102291_bib10","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.addr.2014.01.008","article-title":"Ultrasound-mediated blood-brain barrier disruption for targeted drug delivery in the central nervous system","volume":"72","author":"Aryal","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.arr.2024.102291_bib11","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1055\/s-0039-1678581","article-title":"Current and future treatments in Alzheimer's disease","volume":"39","author":"Atri","year":"2019","journal-title":"Semin Neurol."},{"key":"10.1016\/j.arr.2024.102291_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101339","article-title":"Effects of monoclonal antibodies against amyloid-beta on clinical and biomarker outcomes and adverse event risks: a systematic review and meta-analysis of phase III RCTs in Alzheimer's disease.","volume":"68","author":"Avgerinos","year":"2021","journal-title":"Ageing Res Rev."},{"key":"10.1016\/j.arr.2024.102291_bib13","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S1359-6446(04)03354-9","article-title":"Cell culture-based models for intestinal permeability: a critique","volume":"10","author":"Balimane","year":"2005","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.arr.2024.102291_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2003.12.016","article-title":"The blood-brain barrier: an overview","volume":"16","author":"Ballabh","year":"2004","journal-title":"Struct., Regul., Clin. Implic. Neurobiol. Dis."},{"key":"10.1016\/j.arr.2024.102291_bib15","doi-asserted-by":"crossref","first-page":"8083","DOI":"10.1038\/s41598-017-07416-0","article-title":"A low permeability microfluidic blood-brain barrier platform with direct contact between perfusable vascular network and astrocytes","volume":"7","author":"Bang","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2024.102291_bib16","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.addr.2011.12.005","article-title":"Drug delivery to the brain in Alzheimer's disease: consideration of the blood-brain barrier","volume":"64","author":"Banks","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.arr.2024.102291_bib17","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nrd.2015.21","article-title":"From blood-brain barrier to blood-brain interface: new opportunities for CNS drug delivery","volume":"15","author":"Banks","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.arr.2024.102291_bib18","first-page":"E1","article-title":"Peptide transport systems for opiates across the blood-brain barrier","volume":"259","author":"Banks","year":"1990","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.arr.2024.102291_bib19","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1016\/S0024-3205(96)00380-3","article-title":"Passage of peptides across the blood-brain barrier: pathophysiological perspectives","volume":"59","author":"Banks","year":"1996","journal-title":"Life Sci."},{"key":"10.1016\/j.arr.2024.102291_bib20","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/S0196-9781(97)00198-8","article-title":"Selective, physiological transport of insulin across the blood-brain barrier: novel demonstration by species-specific radioimmunoassays","volume":"18","author":"Banks","year":"1997","journal-title":"Peptides"},{"key":"10.1016\/j.arr.2024.102291_bib21","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12987-019-0154-5","article-title":"Effect of blood contamination of cerebrospinal fluid on amino acids, biogenic amines, pterins and vitamins","volume":"16","author":"Batllori","year":"2019","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.arr.2024.102291_bib22","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1177\/153537020523000206","article-title":"Modulation of p-glycoprotein transport function at the blood-brain barrier","volume":"230","author":"Bauer","year":"2005","journal-title":"Exp. Biol. Med (Maywood)"},{"key":"10.1016\/j.arr.2024.102291_bib23","doi-asserted-by":"crossref","first-page":"73","DOI":"10.4252\/wjsc.v8.i3.73","article-title":"Homing and migration of mesenchymal stromal cells: how to improve the efficacy of cell therapy?","volume":"8","author":"Becker","year":"2016","journal-title":"World J. Stem Cells"},{"key":"10.1016\/j.arr.2024.102291_bib24","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.pharmthera.2004.08.001","article-title":"Delivery of therapeutic agents to the central nervous system: the problems and the possibilities","volume":"104","author":"Begley","year":"2004","journal-title":"Pharm. Ther."},{"key":"10.1016\/j.arr.2024.102291_bib25","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.neuron.2010.09.043","article-title":"Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging","volume":"68","author":"Bell","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.arr.2024.102291_bib26","series-title":"Dynamic light scattering: with applications to chemistry, biology, and physics","article-title":"Dover ed","author":"Berne","year":"2000"},{"key":"10.1016\/j.arr.2024.102291_bib27","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005593","article-title":"Cholinesterase inhibitors for Alzheimer's disease","author":"Birks","year":"2006","journal-title":"Cochrane Database Syst. Rev. 2006, CD005593"},{"issue":"6","key":"10.1016\/j.arr.2024.102291_bib28","article-title":"Donepezil for dementia due to Alzheimer's disease","author":"Birks","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.arr.2024.102291_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022892","article-title":"Microfluidic perfusion for regulating diffusible signaling in stem cells","volume":"6","author":"Blagovic","year":"2011","journal-title":"PLoS One"},{"issue":"Pt 1","key":"10.1016\/j.arr.2024.102291_bib30","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.mod.2015.07.007","article-title":"Formation and maintenance of the BBB","volume":"138","author":"Blanchette","year":"2015","journal-title":"Mech. Dev."},{"key":"10.1016\/j.arr.2024.102291_bib31","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1007\/s11095-016-1958-5","article-title":"Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date","volume":"33","author":"Bobo","year":"2016","journal-title":"Pharm. Res"},{"key":"10.1016\/j.arr.2024.102291_bib32","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.tips.2005.11.009","article-title":"Use of P-glycoprotein and BCRP inhibitors to improve oral bioavailability and CNS penetration of anticancer drugs","volume":"27","author":"Breedveld","year":"2006","journal-title":"Trends Pharm. Sci."},{"key":"10.1016\/j.arr.2024.102291_bib33","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1148\/radiol.14140245","article-title":"Alzheimer disease in a mouse model: MR imaging-guided focused ultrasound targeted to the hippocampus opens the blood-brain barrier and improves pathologic abnormalities and behavior","volume":"273","author":"Burgess","year":"2014","journal-title":"Radiology"},{"key":"10.1016\/j.arr.2024.102291_bib34","first-page":"14","article-title":"Polymeric nanocarriers: a transformation in doxorubicin therapies","author":"Butowska","year":"2021","journal-title":"Mater. (Basel)"},{"key":"10.1016\/j.arr.2024.102291_bib35","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1126\/science.282.5391.1111","article-title":"Nanoengineering of inorganic and hybrid hollow spheres by colloidal templating","volume":"282","author":"Caruso","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.arr.2024.102291_bib36","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.1073\/pnas.0711622105","article-title":"Simultaneous in vivo positron emission tomography and magnetic resonance imaging","volume":"105","author":"Catana","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.arr.2024.102291_bib37","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.cell.2015.07.022","article-title":"A call for systematic research on solute carriers","volume":"162","author":"Cesar-Razquin","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.arr.2024.102291_bib38","doi-asserted-by":"crossref","first-page":"E329","DOI":"10.1208\/pt060243","article-title":"Cyclodextrins in drug delivery: an updated review","volume":"6","author":"Challa","year":"2005","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.arr.2024.102291_bib39","article-title":"Hyperbaric oxygen ameliorates cognitive impairment in patients with Alzheimer's disease and amnestic mild cognitive impairment","volume":"6","author":"Chen","year":"2020","journal-title":"Alzheimers Dement (N. Y"},{"key":"10.1016\/j.arr.2024.102291_bib40","doi-asserted-by":"crossref","first-page":"742","DOI":"10.4103\/1673-5374.230303","article-title":"Use of curcumin in diagnosis, prevention, and treatment of Alzheimer's disease","volume":"13","author":"Chen","year":"2018","journal-title":"Neural Regen. Res"},{"key":"10.1016\/j.arr.2024.102291_bib41","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1126\/science.aaq1144","article-title":"Near-infrared deep brain stimulation via upconversion nanoparticle-mediated optogenetics","volume":"359","author":"Chen","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.arr.2024.102291_bib42","doi-asserted-by":"crossref","first-page":"5137","DOI":"10.1002\/smll.201400654","article-title":"Blood-brain barrier permeable gold nanoparticles: an efficient delivery platform for enhanced malignant glioma therapy and imaging","volume":"10","author":"Cheng","year":"2014","journal-title":"Small"},{"key":"10.1016\/j.arr.2024.102291_bib43","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1021\/acsnano.9b08142","article-title":"Meta-analysis of nanoparticle delivery to tumors using a physiologically based pharmacokinetic modeling and simulation approach","volume":"14","author":"Cheng","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.arr.2024.102291_bib44","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1038\/mp.2015.129","article-title":"Midlife adiposity predicts earlier onset of Alzheimer's dementia, neuropathology and presymptomatic cerebral amyloid accumulation","volume":"21","author":"Chuang","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.arr.2024.102291_bib45","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1016\/j.neuron.2023.04.020","article-title":"Synaptic oligomeric tau in Alzheimer's disease:\u00a0a potential culprit in the spread of tau pathology through the brain","volume":"111","author":"Colom-Cadena","year":"2023","journal-title":"Neuron"},{"key":"10.1016\/j.arr.2024.102291_bib46","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1073\/pnas.86.2.695","article-title":"Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites","volume":"86","author":"Cordon-Cardo","year":"1989","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.arr.2024.102291_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-011-0847-6","article-title":"Brain microvascular pericytes in health and disease","volume":"122","author":"Dalkara","year":"2011","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.arr.2024.102291_bib48","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/ana.23648","article-title":"The blood-brain barrier in health and disease","volume":"72","author":"Daneman","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.arr.2024.102291_bib49","doi-asserted-by":"crossref","first-page":"a020412","DOI":"10.1101\/cshperspect.a020412","article-title":"The blood-brain barrier","volume":"7","author":"Daneman","year":"2015","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.arr.2024.102291_bib50","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/nature09513","article-title":"Pericytes are required for blood-brain barrier integrity during embryogenesis","volume":"468","author":"Daneman","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.arr.2024.102291_bib51","doi-asserted-by":"crossref","DOI":"10.3390\/mps4010010","article-title":"Recent Advances in miRNA Delivery Systems","volume":"4","author":"Dasgupta","year":"2021","journal-title":"Methods Protoc."},{"key":"10.1016\/j.arr.2024.102291_bib52","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/S0092-8674(00)81812-7","article-title":"Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning","volume":"87","author":"Davis","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.arr.2024.102291_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2013.06.001","article-title":"Endothelial calcium dynamics, connexin channels and blood-brain barrier function","volume":"108","author":"De Bock","year":"2013","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.arr.2024.102291_bib54","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1023\/A:1008192010023","article-title":"Lipophilicity in PK design: methyl, ethyl, futile","volume":"15","author":"van de Waterbeemd","year":"2001","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.arr.2024.102291_bib55","doi-asserted-by":"crossref","first-page":"11495","DOI":"10.1523\/JNEUROSCI.3697-05.2005","article-title":"IgG-assisted age-dependent clearance of Alzheimer's amyloid beta peptide by the blood-brain barrier neonatal Fc receptor","volume":"25","author":"Deane","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.arr.2024.102291_bib56","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1111\/j.1471-4159.1990.tb01236.x","article-title":"An easier, reproducible, and mass-production method to study the blood-brain barrier in vitro","volume":"54","author":"Dehouck","year":"1990","journal-title":"J. Neurochem"},{"key":"10.1016\/j.arr.2024.102291_bib57","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/s42003-021-02285-w","article-title":"Integration of substrate- and flow-derived stresses in endothelial cell mechanobiology","volume":"4","author":"Dessalles","year":"2021","journal-title":"Commun. Biol."},{"key":"10.1016\/j.arr.2024.102291_bib58","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/nrc.2017.93","article-title":"Transport of drugs from blood vessels to tumour tissue","volume":"17","author":"Dewhirst","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.arr.2024.102291_bib59","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.1097\/SAP.0000000000001947","article-title":"Cell-based therapies for chronic wounds tested in clinical studies: review","volume":"83","author":"Domaszewska-Szostek","year":"2019","journal-title":"Ann. Plast. Surg."},{"key":"10.1016\/j.arr.2024.102291_bib60","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMoa1210951","article-title":"A phase 3 trial of semagacestat for treatment of Alzheimer's disease","volume":"369","author":"Doody","year":"2013","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.arr.2024.102291_bib61","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s13195-023-01314-6","article-title":"Biomarkers in Alzheimer\u2019s disease: role in early and differential diagnosis and recognition of atypical variants","volume":"15","author":"Dubois","year":"2023","journal-title":"Alzheimer'S. Res. Ther."},{"key":"10.1016\/j.arr.2024.102291_bib62","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early Alzheimer's disease","volume":"388","author":"van Dyck","year":"2023","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.arr.2024.102291_bib63","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ejpb.2016.03.029","article-title":"In vitro blood-brain barrier permeability predictions for GABAA receptor modulating piperine analogs","volume":"103","author":"Eigenmann","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.arr.2024.102291_bib64","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.5123","article-title":"Assessment of brain-to-blood drug distribution using liquid chromatography","volume":"35","author":"El Zahar","year":"2021","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.arr.2024.102291_bib65","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/sj.jcbfm.9600249","article-title":"The rat blood-brain barrier transcriptome","volume":"26","author":"Enerson","year":"2006","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"10.1016\/j.arr.2024.102291_bib66","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1021\/nn900002m","article-title":"Impact of nanotechnology on drug delivery","volume":"3","author":"Farokhzad","year":"2009","journal-title":"ACS Nano"},{"key":"10.1016\/j.arr.2024.102291_bib67","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1517\/17425247.5.1.25","article-title":"Liposomal nanomedicines","volume":"5","author":"Fenske","year":"2008","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.arr.2024.102291_bib68","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.neuroimage.2018.06.029","article-title":"A magnetic resonance multi-atlas for the neonatal rabbit brain","volume":"179","author":"Ferraris","year":"2018","journal-title":"Neuroimage"},{"key":"10.1016\/j.arr.2024.102291_bib69","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s002329900434","article-title":"Blood-brain barrier permeation: molecular parameters governing passive diffusion","volume":"165","author":"Fischer","year":"1998","journal-title":"J. Membr. Biol."},{"key":"10.1016\/j.arr.2024.102291_bib70","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/jnr.490180206","article-title":"Receptor-mediated transcytosis of transferrin across the blood-brain barrier","volume":"18","author":"Fishman","year":"1987","journal-title":"J. Neurosci. Res"},{"key":"10.1016\/j.arr.2024.102291_bib71","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s00232-015-9778-9","article-title":"Permeability of the blood-brain barrier: molecular mechanism of transport of drugs and physiologically important compounds","volume":"248","author":"Fong","year":"2015","journal-title":"J. Membr. Biol."},{"issue":"Suppl 2","key":"10.1016\/j.arr.2024.102291_bib72","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1046\/j.1365-2362.33.s2.4.x","article-title":"Importance of P-glycoprotein for drug disposition in humans","volume":"33","author":"Fromm","year":"2003","journal-title":"Eur. J. Clin. Invest"},{"key":"10.1016\/j.arr.2024.102291_bib73","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.tips.2004.06.002","article-title":"Importance of P-glycoprotein at blood-tissue barriers","volume":"25","author":"Fromm","year":"2004","journal-title":"Trends Pharm. Sci."},{"key":"10.1016\/j.arr.2024.102291_bib74","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s41544-019-0024-y","article-title":"Recent progress in microRNA-based delivery systems for the treatment of human disease","volume":"1","author":"Fu","year":"2019","journal-title":"ExRNA"},{"key":"10.1016\/j.arr.2024.102291_bib75","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1248\/cpb.c21-00961","article-title":"Biomimetic nanoparticle drug delivery systems to overcome biological barriers for therapeutic applications","volume":"70","author":"Fukuta","year":"2022","journal-title":"Chem. Pharm. Bull. (Tokyo)"},{"key":"10.1016\/j.arr.2024.102291_bib76","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1074\/jbc.275.3.1699","article-title":"beta-lactam antibiotics as substrates for OCTN2, an organic cation\/carnitine transporter","volume":"275","author":"Ganapathy","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2024.102291_bib77","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1111\/bph.13816","article-title":"Nano-curcumin safely prevents streptozotocin-induced inflammation and apoptosis in pancreatic beta cells for effective management of Type 1 diabetes mellitus","volume":"174","author":"Ganugula","year":"2017","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.arr.2024.102291_bib78","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jconrel.2005.09.034","article-title":"Block copolymer micelles: preparation, characterization and application in drug delivery","volume":"109","author":"Gaucher","year":"2005","journal-title":"J. Control Release"},{"key":"10.1016\/j.arr.2024.102291_bib79","doi-asserted-by":"crossref","first-page":"961","DOI":"10.4155\/tde.15.32","article-title":"Molecular determinants of blood-brain barrier permeation","volume":"6","author":"Geldenhuys","year":"2015","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.arr.2024.102291_bib80","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1021\/cn200100h","article-title":"Knowledge-based, central nervous system (CNS) lead selection and lead optimization for CNS drug discovery","volume":"3","author":"Ghose","year":"2012","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.arr.2024.102291_bib81","doi-asserted-by":"crossref","first-page":"883","DOI":"10.2174\/1570159X18666200429011823","article-title":"Current status of drug targets and emerging therapeutic strategies in the management of Alzheimer's disease","volume":"18","author":"Ghosh","year":"2020","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.arr.2024.102291_bib82","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1146\/annurev.bi.62.070193.002125","article-title":"Biochemistry of multidrug resistance mediated by the multidrug transporter","volume":"62","author":"Gottesman","year":"1993","journal-title":"Annu Rev. Biochem"},{"key":"10.1016\/j.arr.2024.102291_bib83","doi-asserted-by":"crossref","DOI":"10.3390\/biom11101520","article-title":"Hyperbaric oxygen treatment-from mechanisms to cognitive improvement","volume":"11","author":"Gottfried","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.arr.2024.102291_bib84","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0168-3659(98)00116-3","article-title":"PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug","volume":"57","author":"Govender","year":"1999","journal-title":"J. Control Release"},{"key":"10.1016\/j.arr.2024.102291_bib85","doi-asserted-by":"crossref","DOI":"10.1002\/mabi.202100007","article-title":"Construction of poly(amidoamine) dendrimer\/carbon dot nanohybrids for biomedical applications","volume":"21","author":"Guo","year":"2021","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.arr.2024.102291_bib86","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s00424-003-1168-y","article-title":"Organic anion transporting polypeptides of the OATP\/ SLC21 family: phylogenetic classification as OATP\/ SLCO superfamily, new nomenclature and molecular\/functional properties","volume":"447","author":"Hagenbuch","year":"2004","journal-title":"Pflug. Arch."},{"key":"10.1016\/j.arr.2024.102291_bib87","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1007\/s13311-019-00779-4","article-title":"The Medical Management of cerebral edema: past, present, and future therapies","volume":"16","author":"Halstead","year":"2019","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.arr.2024.102291_bib88","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1093\/brain\/awy132","article-title":"The cholinergic system in the pathophysiology and treatment of Alzheimer's disease","volume":"141","author":"Hampel","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.arr.2024.102291_bib89","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2202-9-S3-S5","article-title":"Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease","volume":"9","author":"Hanson","year":"2008","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.arr.2024.102291_bib90","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1111\/jphp.13132","article-title":"Advancements in nanotherapeutics for Alzheimer's disease: current perspectives","volume":"71","author":"Harilal","year":"2019","journal-title":"J. Pharm. Pharm."},{"key":"10.1016\/j.arr.2024.102291_bib91","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.brainresbull.2020.03.018","article-title":"Revisiting the blood-brain barrier: a hard nut to crack in the transportation of drug molecules","volume":"160","author":"Harilal","year":"2020","journal-title":"Brain Res Bull."},{"key":"10.1016\/j.arr.2024.102291_bib92","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1124\/mol.104.001503","article-title":"Rapid regulation of P-glycoprotein at the blood-brain barrier by endothelin-1","volume":"66","author":"Hartz","year":"2004","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.arr.2024.102291_bib93","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1124\/mol.109.061754","article-title":"Restoring blood-brain barrier P-glycoprotein reduces brain amyloid-beta in a mouse model of Alzheimer's disease","volume":"77","author":"Hartz","year":"2010","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.arr.2024.102291_bib94","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0005-2736(00)00252-2","article-title":"Primary structure, functional characteristics and tissue expression pattern of human ATA2, a subtype of amino acid transport system A","volume":"1467","author":"Hatanaka","year":"2000","journal-title":"Biochim Biophys. Acta"},{"key":"10.1016\/j.arr.2024.102291_bib95","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1124\/pr.57.2.4","article-title":"The blood-brain barrier\/neurovascular unit in health and disease","volume":"57","author":"Hawkins","year":"2005","journal-title":"Pharm. Rev."},{"key":"10.1016\/j.arr.2024.102291_bib96","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1177\/0271678X16630991","article-title":"In vitro models of the blood-brain barrier: An overview of commonly used brain endothelial cell culture models and guidelines for their use","volume":"36","author":"Helms","year":"2016","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"10.1016\/j.arr.2024.102291_bib97","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1172\/JCI200113992","article-title":"LRP: a multifunctional scavenger and signaling receptor","volume":"108","author":"Herz","year":"2001","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.arr.2024.102291_bib98","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.clpt.2005.05.011","article-title":"Transporters and drug therapy: implications for drug disposition and disease","volume":"78","author":"Ho","year":"2005","journal-title":"Clin. Pharm. Ther."},{"key":"10.1016\/j.arr.2024.102291_bib99","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1056\/NEJMoa1106668","article-title":"Donepezil and Memantine for Moderate-to-Severe Alzheimer's Disease","volume":"366","author":"Howard","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.arr.2024.102291_bib100","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1016\/j.peptides.2007.10.007","article-title":"The fasting polypeptide FGF21 can enter brain from blood","volume":"28","author":"Hsuchou","year":"2007","journal-title":"Peptides"},{"key":"10.1016\/j.arr.2024.102291_bib101","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.colsurfb.2005.08.005","article-title":"Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system","volume":"45","author":"Hu","year":"2005","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.arr.2024.102291_bib102","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.3389\/fphar.2019.01328","article-title":"Advances in Nanoparticulate Drug Delivery Approaches for Sublingual and Buccal Administration","volume":"10","author":"Hua","year":"2019","journal-title":"Front Pharm."},{"key":"10.1016\/j.arr.2024.102291_bib103","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s13238-016-0350-x","article-title":"Functional characterization of human equilibrative nucleoside transporter 1","volume":"8","author":"Huang","year":"2017","journal-title":"Protein Cell"},{"key":"10.1016\/j.arr.2024.102291_bib104","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0928-0987(00)00087-7","article-title":"Transport of drugs from the nasal cavity to the central nervous system","volume":"11","author":"Illum","year":"2000","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.arr.2024.102291_bib105","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/S1359-6446(02)02529-1","article-title":"Nasal drug delivery: new developments and strategies","volume":"7","author":"Illum","year":"2002","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.arr.2024.102291_bib106","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrd3028","article-title":"Membrane transporters in drug development","volume":"9","author":"International Transporter","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.arr.2024.102291_bib107","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.2174\/1389450119666180131105822","article-title":"Nanocarrier Based Advances in Drug Delivery to Tumor: An Overview","volume":"19","author":"Jain","year":"2018","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.arr.2024.102291_bib108","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.biomaterials.2010.09.037","article-title":"The effect of the oral administration of polymeric nanoparticles on the efficacy and toxicity of tamoxifen","volume":"32","author":"Jain","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.arr.2024.102291_bib109","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s13205-014-0214-0","article-title":"Nanoemulsion: an advanced mode of drug delivery system","volume":"5","author":"Jaiswal","year":"2015","journal-title":"3 Biotech"},{"key":"10.1016\/j.arr.2024.102291_bib110","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1023\/A:1025785505977","article-title":"Drug delivery and transport to solid tumors","volume":"20","author":"Jang","year":"2003","journal-title":"Pharm. Res"},{"key":"10.1016\/j.arr.2024.102291_bib111","doi-asserted-by":"crossref","first-page":"30069","DOI":"10.1074\/jbc.M005463200","article-title":"The multidrug resistance protein 5 functions as an ATP-dependent export pump for cyclic nucleotides","volume":"275","author":"Jedlitschky","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2024.102291_bib112","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/312162a0","article-title":"Transferrin receptor on endothelium of brain capillaries","volume":"312","author":"Jefferies","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.arr.2024.102291_bib113","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1039\/c2cs15344k","article-title":"Targeted polymeric therapeutic nanoparticles: design, development and clinical translation","volume":"41","author":"Kamaly","year":"2012","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.arr.2024.102291_bib114","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.2147\/IJN.S360161","article-title":"Multifunctional Theranostic Nanoparticles for Enhanced Tumor Targeted Imaging and Synergistic FUS\/Chemotherapy on Murine 4T1 Breast Cancer Cell","volume":"17","author":"Kang","year":"2022","journal-title":"Int J. Nanomed."},{"key":"10.1016\/j.arr.2024.102291_bib115","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1021\/jm970530e","article-title":"Physicochemical high throughput screening: parallel artificial membrane permeation assay in the description of passive absorption processes","volume":"41","author":"Kansy","year":"1998","journal-title":"J. Med Chem."},{"key":"10.1016\/j.arr.2024.102291_bib116","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S1359-6446(03)02649-7","article-title":"Pharmaceutical profiling in drug discovery","volume":"8","author":"Kerns","year":"2003","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.arr.2024.102291_bib117","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1089\/neu.2008.0818","article-title":"Therapeutic effects of human mesenchymal stem cells on traumatic brain injury in rats: secretion of neurotrophic factors and inhibition of apoptosis","volume":"27","author":"Kim","year":"2010","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.arr.2024.102291_bib118","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1017\/S0033291716000064","article-title":"Single-dose infusion ketamine and non-ketamine N-methyl-d-aspartate receptor antagonists for unipolar and bipolar depression: a meta-analysis of efficacy, safety and time trajectories","volume":"46","author":"Kishimoto","year":"2016","journal-title":"Psychol. Med"},{"key":"10.1016\/j.arr.2024.102291_bib119","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/pj.2014.40","article-title":"Surface engineering of nanoparticles for therapeutic applications","volume":"46","author":"Kobayashi","year":"2014","journal-title":"Polym. J."},{"key":"10.1016\/j.arr.2024.102291_bib120","article-title":"Structure and pathology of tau protein in Alzheimer disease","volume":"2012","author":"Kolarova","year":"2012","journal-title":"Int J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2024.102291_bib121","first-page":"1525","article-title":"Exosome mimetics: a novel class of drug delivery systems","author":"Kooijmans","year":"2012","journal-title":"Int J. Nanomed. 7"},{"key":"10.1016\/j.arr.2024.102291_bib122","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.addr.2013.08.008","article-title":"Drug delivery to the central nervous system by polymeric nanoparticles: what do we know?","volume":"71","author":"Kreuter","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.arr.2024.102291_bib123","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abb3945","article-title":"A first-in-human phase 0 clinical study of RNA interference-based spherical nucleic acids in patients with recurrent glioblastoma","volume":"13","author":"Kumthekar","year":"2021","journal-title":"Sci. Transl. Med"},{"key":"10.1016\/j.arr.2024.102291_bib124","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.brs.2016.02.011","article-title":"Transcranial Magnetic Stimulation of Left Dorsolateral Prefrontal Cortex Induces Brain Morphological Changes in Regions Associated with a Treatment Resistant Major Depressive Episode: An Exploratory Analysis","volume":"9","author":"Lan","year":"2016","journal-title":"Brain Stimul."},{"key":"10.1016\/j.arr.2024.102291_bib125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0109113","article-title":"A multi-atlas based method for automated anatomical rat brain MRI segmentation and extraction of PET activity","volume":"9","author":"Lancelot","year":"2014","journal-title":"PLoS One"},{"issue":"Suppl 1","key":"10.1016\/j.arr.2024.102291_bib126","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1097\/j.pain.0000000000000401","article-title":"Cortical neurostimulation for neuropathic pain: state of the art and perspectives","volume":"157","author":"Lefaucheur","year":"2016","journal-title":"Pain"},{"key":"10.1016\/j.arr.2024.102291_bib127","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.2174\/1567205014666170203125008","article-title":"Nanotechnology for Alzheimer Disease","volume":"14","author":"Leszek","year":"2017","journal-title":"Curr. Alzheimer Res"},{"key":"10.1016\/j.arr.2024.102291_bib128","doi-asserted-by":"crossref","DOI":"10.1016\/j.trac.2021.116318","article-title":"Recent advances in sample preparation techniques for quantitative detection of pharmaceuticals in biological samples","volume":"142","author":"Li","year":"2021","journal-title":"TrAC Trends Anal. Chem."},{"key":"10.1016\/j.arr.2024.102291_bib129","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2165\/00003088-200342010-00003","article-title":"Role of P-glycoprotein in pharmacokinetics: clinical implications","volume":"42","author":"Lin","year":"2003","journal-title":"Clin. Pharm."},{"key":"10.1016\/j.arr.2024.102291_bib130","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/5550938","article-title":"The Potential Benefits of Nanotechnology in Treating Alzheimer's Disease","volume":"2021","author":"Ling","year":"2021","journal-title":"Biomed. Res Int"},{"key":"10.1016\/j.arr.2024.102291_bib131","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.arr.2024.102291_bib132","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/2045-8118-10-2","article-title":"Modeling the blood-brain barrier using stem cell sources","volume":"10","author":"Lippmann","year":"2013","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.arr.2024.102291_bib133","article-title":"Brain-targeting drug delivery systems","volume":"14","author":"Liu","year":"2022","journal-title":"Wiley Inter. Rev. Nanomed. Nanobiotechnol"},{"key":"10.1016\/j.arr.2024.102291_bib134","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.pharmthera.2018.01.007","article-title":"Thyroid hormone and the brain: Mechanisms of action in development and role in protection and promotion of recovery after brain injury","volume":"186","author":"Liu","year":"2018","journal-title":"Pharm. Ther."},{"key":"10.1016\/j.arr.2024.102291_bib135","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.pneurobio.2005.04.006","article-title":"Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases","volume":"76","author":"Loscher","year":"2005","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.arr.2024.102291_bib136","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nrn1728","article-title":"Drug resistance in brain diseases and the role of drug efflux transporters","volume":"6","author":"Loscher","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.arr.2024.102291_bib137","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1089\/hum.1994.5.2-203","article-title":"High efficiency retroviral-mediated gene transduction into CD34+ cells purified from peripheral blood of breast cancer patients primed with chemotherapy and granulocyte-macrophage colony-stimulating factor","volume":"5","author":"Lu","year":"1994","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.arr.2024.102291_bib138","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1021\/la00026a020","article-title":"Assembly, structural characterization, and thermal behavior of layer-by-layer deposited ultrathin films of poly(vinyl sulfate) and poly(allylamine)","volume":"9","author":"Lvov","year":"1993","journal-title":"Langmuir"},{"key":"10.1016\/j.arr.2024.102291_bib139","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.neuropharm.2016.08.025","article-title":"Targeting blood-brain-barrier transcytosis - perspectives for drug delivery","volume":"120","author":"M\u00e4ger","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.arr.2024.102291_bib140","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1096\/fasebj.8.13.7926364","article-title":"Glucose transporter proteins in brain","volume":"8","author":"Maher","year":"1994","journal-title":"FASEB J."},{"key":"10.1016\/j.arr.2024.102291_bib141","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222312789","article-title":"Transmission Electron Microscopy as a Powerful Tool to Investigate the Interaction of Nanoparticles with Subcellular Structures","volume":"22","author":"Malatesta","year":"2021","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.arr.2024.102291_bib142","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1002\/hep.20898","article-title":"Altered disposition of acetaminophen in mice with a disruption of the Mrp3 gene","volume":"42","author":"Manautou","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.arr.2024.102291_bib143","doi-asserted-by":"crossref","DOI":"10.1016\/j.disamonth.2023.101547","article-title":"Newer modalities in the management of Alzheimer's dementia along with the role of aducanumab and lecanemab in the treatment of its refractory cases","volume":"69","author":"Marsool","year":"2023","journal-title":"Dis. Mon."},{"key":"10.1016\/j.arr.2024.102291_bib144","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003154.pub6","article-title":"Memantine for dementia","author":"McShane","year":"2019","journal-title":"Cochrane Database Syst. Rev. 3, CD003154"},{"key":"10.1016\/j.arr.2024.102291_bib145","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/bs.acr.2014.10.002","article-title":"Regulation of ABC transporters blood-brain barrier: the good, the bad, and the ugly","author":"Miller","year":"2015","journal-title":"Adv. Cancer Res 125"},{"key":"10.1016\/j.arr.2024.102291_bib146","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.arr.2024.102291_bib147","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.addr.2015.03.001","article-title":"Prediction of drug-ABC-transporter interaction--Recent advances and future challenges","volume":"86","author":"Montanari","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.arr.2024.102291_bib148","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/(SICI)1097-4547(19981115)54:4<486::AID-JNR6>3.0.CO;2-I","article-title":"Evidence for low molecular weight, non-transferrin-bound iron in rat brain and cerebrospinal fluid","volume":"54","author":"Moos","year":"1998","journal-title":"J. Neurosci. Res"},{"key":"10.1016\/j.arr.2024.102291_bib149","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1046\/j.1471-4159.2001.00541.x","article-title":"Restricted transport of anti-transferrin receptor antibody (OX26) through the blood-brain barrier in the rat","volume":"79","author":"Moos","year":"2001","journal-title":"J. Neurochem"},{"key":"10.1016\/j.arr.2024.102291_bib150","doi-asserted-by":"crossref","first-page":"12871","DOI":"10.1039\/C8NR02278J","article-title":"Characterization techniques for nanoparticles: comparison and complementarity upon studying nanoparticle properties","volume":"10","author":"Mourdikoudis","year":"2018","journal-title":"Nanoscale"},{"key":"10.1016\/j.arr.2024.102291_bib151","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/j.ijbiomac.2020.07.327","article-title":"Role of tau protein in Alzheimer's disease: The prime pathological player","volume":"163","author":"Muralidar","year":"2020","journal-title":"Int J. Biol. Macromol."},{"key":"10.1016\/j.arr.2024.102291_bib152","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/s41578-021-00394-w","article-title":"Drug delivery to the central nervous system","volume":"7","author":"Nance","year":"2022","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.arr.2024.102291_bib153","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nmat2442","article-title":"Understanding biophysicochemical interactions at the nano-bio interface","volume":"8","author":"Nel","year":"2009","journal-title":"Nat. Mater."},{"key":"10.1016\/j.arr.2024.102291_bib154","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nrn2995","article-title":"Engaging neuroscience to advance translational research in brain barrier biology","volume":"12","author":"Neuwelt","year":"2011","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.arr.2024.102291_bib155","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s11095-020-02867-z","article-title":"Impact of In Vitro Passive Permeability in a P-gp-transfected LLC-PK1 Model on the Prediction of the Rat and Human Unbound Brain-to-Plasma Concentration Ratio","volume":"37","author":"Nicola\u00ef","year":"2020","journal-title":"Pharm. Res"},{"key":"10.1016\/j.arr.2024.102291_bib156","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1517\/17425255.2012.722996","article-title":"Multidrug and toxin extrusion proteins as transporters of antimicrobial drugs","volume":"8","author":"Nies","year":"2012","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.arr.2024.102291_bib157","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1177\/1073858418810142","article-title":"Brain-Derived Neurotrophic Factor (BDNF): Novel Insights into Regulation and Genetic Variation","volume":"25","author":"Notaras","year":"2019","journal-title":"Neuroscientist"},{"key":"10.1016\/j.arr.2024.102291_bib158","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1038\/nm.3407","article-title":"Development, maintenance and disruption of the blood-brain barrier","volume":"19","author":"Obermeier","year":"2013","journal-title":"Nat. Med"},{"key":"10.1016\/j.arr.2024.102291_bib159","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1016\/j.addr.2013.09.014","article-title":"Nanocarriers for delivery of platinum anticancer drugs","volume":"65","author":"Oberoi","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.arr.2024.102291_bib160","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.tibtech.2019.04.006","article-title":"Advances in Microfluidic Blood-Brain Barrier (BBB) Models","volume":"37","author":"Oddo","year":"2019","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.arr.2024.102291_bib161","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1007\/s11095-007-9374-5","article-title":"Contribution of carrier-mediated transport systems to the blood-brain barrier as a supporting and protecting interface for the brain; importance for CNS drug discovery and development","volume":"24","author":"Ohtsuki","year":"2007","journal-title":"Pharm. Res"},{"key":"10.1016\/j.arr.2024.102291_bib162","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13195-017-0318-y","article-title":"A phase III randomized trial of gantenerumab in prodromal Alzheimer's disease","volume":"9","author":"Ostrowitzki","year":"2017","journal-title":"Alzheimers Res Ther."},{"key":"10.1016\/j.arr.2024.102291_bib163","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/6910811","article-title":"A Potential Notion on Alzheimer\u2019s Disease: Nanotechnology as an Alternative Solution","volume":"2022","author":"Pange","year":"2022","journal-title":"J. Nanomater."},{"key":"10.1016\/j.arr.2024.102291_bib164","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1023\/A:1022482604276","article-title":"Blood-brain barrier carrier-mediated transport and brain metabolism of amino acids","volume":"23","author":"Pardridge","year":"1998","journal-title":"Neurochem Res"},{"key":"10.1016\/j.arr.2024.102291_bib165","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1602\/neurorx.2.1.3","article-title":"The blood-brain barrier: bottleneck in brain drug development","volume":"2","author":"Pardridge","year":"2005","journal-title":"NeuroRx"},{"key":"10.1016\/j.arr.2024.102291_bib166","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1007\/s11095-007-9324-2","article-title":"Drug targeting to the brain","volume":"24","author":"Pardridge","year":"2007","journal-title":"Pharm. Res"},{"key":"10.1016\/j.arr.2024.102291_bib167","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.drudis.2006.10.013","article-title":"Blood-brain barrier delivery","volume":"12","author":"Pardridge","year":"2007","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.arr.2024.102291_bib168","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1038\/jcbfm.2012.126","article-title":"Drug transport across the blood-brain barrier","volume":"32","author":"Pardridge","year":"2012","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"10.1016\/j.arr.2024.102291_bib169","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/B978-0-12-396962-0.00011-2","article-title":"Reengineering biopharmaceuticals for targeted delivery across the blood-brain barrier","volume":"503","author":"Pardridge","year":"2012","journal-title":"Methods Enzym."},{"key":"10.1016\/j.arr.2024.102291_bib170","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1038\/s41467-019-10588-0","article-title":"Hypoxia-enhanced Blood-Brain Barrier Chip recapitulates human barrier function and shuttling of drugs and antibodies","volume":"10","author":"Park","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.arr.2024.102291_bib171","doi-asserted-by":"crossref","first-page":"10938","DOI":"10.1021\/acs.chemrev.5b00046","article-title":"New Developments in Liposomal Drug Delivery","volume":"115","author":"Pattni","year":"2015","journal-title":"Chem. Rev."},{"key":"10.1016\/j.arr.2024.102291_bib172","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nnano.2007.387","article-title":"Nanocarriers as an emerging platform for cancer therapy","volume":"2","author":"Peer","year":"2007","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.arr.2024.102291_bib173","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1021\/acsnano.6b06040","article-title":"Diverse Applications of Nanomedicine","volume":"11","author":"Pelaz","year":"2017","journal-title":"ACS Nano"},{"key":"10.1016\/j.arr.2024.102291_bib174","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1177\/1535370217694100","article-title":"Blood-brain barrier-on-a-chip: Microphysiological systems that capture the complexity of the blood-central nervous system interface","volume":"242","author":"Phan","year":"2017","journal-title":"Exp. Biol. Med (Maywood)"},{"key":"10.1016\/j.arr.2024.102291_bib175","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1039\/c2lc41208j","article-title":"SyM-BBB: a microfluidic Blood Brain Barrier model","volume":"13","author":"Prabhakarpandian","year":"2013","journal-title":"Lab Chip"},{"key":"10.1016\/j.arr.2024.102291_bib176","doi-asserted-by":"crossref","first-page":"eaay9249","DOI":"10.1126\/sciadv.aay9249","article-title":"A reanalysis of nanoparticle tumor delivery using classical pharmacokinetic metrics","volume":"6","author":"Price","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.arr.2024.102291_bib177","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1007\/s11095-022-03241-x","article-title":"Targeting Transporters for Drug Delivery to the Brain: Can We Do Better?","volume":"39","author":"Puris","year":"2022","journal-title":"Pharm. Res"},{"key":"10.1016\/j.arr.2024.102291_bib178","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s00702-012-0902-z","article-title":"Repetitive transcranial magnetic stimulation combined with cognitive training is a safe and effective modality for the treatment of Alzheimer's disease: a randomized, double-blind study","volume":"120","author":"Rabey","year":"2013","journal-title":"J. Neural Transm. (Vienna)"},{"issue":"Suppl 2","key":"10.1016\/j.arr.2024.102291_bib179","doi-asserted-by":"crossref","first-page":"S499","DOI":"10.3233\/JAD-2010-100504","article-title":"Amyloid-beta and mitochondria in aging and Alzheimer's disease: implications for synaptic damage and cognitive decline","volume":"20","author":"Reddy","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2024.102291_bib180","doi-asserted-by":"crossref","first-page":"3624","DOI":"10.2174\/138161212802002625","article-title":"Blood-brain barrier integrity and glial support: mechanisms that can be targeted for novel therapeutic approaches in stroke","volume":"18","author":"Ronaldson","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.arr.2024.102291_bib181","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jconrel.2014.10.015","article-title":"Nano-engineered mesenchymal stem cells as targeted therapeutic carriers","volume":"196","author":"Sadhukha","year":"2014","journal-title":"J. Control Release"},{"key":"10.1016\/j.arr.2024.102291_bib182","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00401-016-1558-9","article-title":"Presynaptic dystrophic neurites surrounding amyloid plaques are sites of microtubule disruption, BACE1 elevation, and increased A\u03b2 generation in Alzheimer's disease","volume":"132","author":"Sadleir","year":"2016","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.arr.2024.102291_bib183","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.neuropharm.2015.07.037","article-title":"Antidepressant-like effects of ketamine, norketamine and dehydronorketamine in forced swim test: Role of activity at NMDA receptor","volume":"99","author":"Salat","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.arr.2024.102291_bib184","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jconrel.2016.05.044","article-title":"Nanoparticle-mediated brain drug delivery: Overcoming blood-brain barrier to treat neurodegenerative diseases","volume":"235","author":"Saraiva","year":"2016","journal-title":"J. Control Release"},{"key":"10.1016\/j.arr.2024.102291_bib185","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/2040-2384-2-14","article-title":"Physiologic upper limits of pore size of different blood capillary types and another perspective on the dual pore theory of microvascular permeability","volume":"2","author":"Sarin","year":"2010","journal-title":"J. Angiogenes Res"},{"key":"10.1016\/j.arr.2024.102291_bib186","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0169-409X(98)00085-4","article-title":"P-Glycoprotein, a gatekeeper in the blood-brain barrier","volume":"36","author":"Schinkel","year":"1999","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.arr.2024.102291_bib187","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(02)00169-2","article-title":"Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview","volume":"55","author":"Schinkel","year":"2003","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.arr.2024.102291_bib188","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.semcdb.2014.04.037","article-title":"Angiogenesis in zebrafish","volume":"31","author":"Schuermann","year":"2014","journal-title":"Semin Cell Dev. Biol."},{"key":"10.1016\/j.arr.2024.102291_bib189","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature19323","article-title":"The antibody aducanumab reduces Abeta plaques in Alzheimer's disease.","volume":"537","author":"Sevigny","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.arr.2024.102291_bib190","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.2174\/1871527315666160819123059","article-title":"Nanowired Drug Delivery Across the Blood-Brain Barrier in Central Nervous System Injury and Repair","volume":"15","author":"Sharma","year":"2016","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.arr.2024.102291_bib191","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.ijpharm.2019.01.056","article-title":"Advances in nanocarriers enabled brain targeted drug delivery across blood brain barrier","volume":"559","author":"Sharma","year":"2019","journal-title":"Int J. Pharm."},{"key":"10.1016\/j.arr.2024.102291_bib192","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/nrc.2016.108","article-title":"Cancer nanomedicine: progress, challenges and opportunities","volume":"17","author":"Shi","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.arr.2024.102291_bib193","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1172\/JCI10498","article-title":"Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier.","volume":"106","author":"Shibata","year":"2000","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.arr.2024.102291_bib194","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13287-017-0523-4","article-title":"Magnetic targeting as a strategy to enhance therapeutic effects of mesenchymal stromal cells","volume":"8","author":"Silva","year":"2017","journal-title":"Stem Cell Res Ther."},{"key":"10.1016\/j.arr.2024.102291_bib195","article-title":"Emerging Nanotechnology for the Treatment of Alzheimer's Disease","author":"Singh","year":"2023","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.arr.2024.102291_bib196","first-page":"193","article-title":"A review of blood-brain barrier transport techniques","volume":"89","author":"Smith","year":"2003","journal-title":"Methods Mol. Med"},{"key":"10.1016\/j.arr.2024.102291_bib197","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.jconrel.2023.07.004","article-title":"Emerging nanotechnology for Alzheimer's disease: From detection to treatment","volume":"360","author":"Song","year":"2023","journal-title":"J. Control Release"},{"key":"10.1016\/j.arr.2024.102291_bib198","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1471-4159.2009.06451.x","article-title":"Nature and consequences of mammalian brain and CSF efflux transporters: four decades of progress","volume":"112","author":"Spector","year":"2010","journal-title":"J. Neurochem"},{"key":"10.1016\/j.arr.2024.102291_bib199","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/scientificamerican1189-68","article-title":"The mammalian choroid plexus","volume":"261","author":"Spector","year":"1989","journal-title":"Sci. Am."},{"key":"10.1016\/j.arr.2024.102291_bib200","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/324968","article-title":"New insights in the amyloid-Beta interaction with mitochondria","volume":"2012","author":"Spuch","year":"2012","journal-title":"J. Aging Res"},{"key":"10.1016\/j.arr.2024.102291_bib201","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1745-6673-2-16","article-title":"Nanotechnology-based drug delivery systems","volume":"2","author":"Suri","year":"2007","journal-title":"J. Occup. Med Toxicol."},{"key":"10.1016\/j.arr.2024.102291_bib202","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","article-title":"Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders","volume":"14","author":"Sweeney","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.arr.2024.102291_bib203","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1152\/physrev.00050.2017","article-title":"Blood-Brain Barrier: From Physiology to Disease and Back","volume":"99","author":"Sweeney","year":"2019","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.arr.2024.102291_bib204","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6528\/ab19d3","article-title":"Magnetic field-assisted selective delivery of doxorubicin to cancer cells using magnetoliposomes as drug nanocarriers","volume":"30","author":"Szuplewska","year":"2019","journal-title":"Nanotechnology"},{"key":"10.1016\/j.arr.2024.102291_bib205","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/2045-8118-8-13","article-title":"Transport characteristics of guanidino compounds at the blood-brain barrier and blood-cerebrospinal fluid barrier: relevance to neural disorders","volume":"8","author":"Tachikawa","year":"2011","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.arr.2024.102291_bib206","doi-asserted-by":"crossref","first-page":"527","DOI":"10.4155\/tde-2019-0044","article-title":"Polymeric nanoparticles as carrier for targeted and controlled delivery of anticancer agents","volume":"10","author":"Taghipour-Sabzevar","year":"2019","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.arr.2024.102291_bib207","first-page":"1590","article-title":"A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting","volume":"49","author":"Tariot","year":"2001","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.arr.2024.102291_bib208","doi-asserted-by":"crossref","first-page":"634","DOI":"10.5966\/sctm.2016-0071","article-title":"Impact of the Secretome of Human Mesenchymal Stem Cells on Brain Structure and Animal Behavior in a Rat Model of Parkinson's Disease","volume":"6","author":"Teixeira","year":"2017","journal-title":"Stem Cells Transl. Med"},{"key":"10.1016\/j.arr.2024.102291_bib209","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/s41573-021-00139-y","article-title":"Strategies for delivering therapeutics across the blood-brain barrier","volume":"20","author":"Terstappen","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.arr.2024.102291_bib210","doi-asserted-by":"crossref","first-page":"11990","DOI":"10.1038\/srep11990","article-title":"LRP-1-mediated intracellular antibody delivery to the Central Nervous System","volume":"5","author":"Tian","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2024.102291_bib211","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.addr.2006.09.009","article-title":"Multifunctional nanocarriers.","volume":"58","author":"Torchilin","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.arr.2024.102291_bib212","doi-asserted-by":"crossref","DOI":"10.1002\/smll.201701921","article-title":"Drug Delivery to the Brain across the Blood-Brain Barrier Using Nanomaterials","volume":"13","author":"Tsou","year":"2017","journal-title":"Small"},{"key":"10.1016\/j.arr.2024.102291_bib213","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1364\/BOE.5.001731","article-title":"In vivo imaging of nanoparticle delivery and tumor microvasculature with multimodal optical coherence tomography","volume":"5","author":"Tucker-Schwartz","year":"2014","journal-title":"Biomed. Opt. Express"},{"key":"10.1016\/j.arr.2024.102291_bib214","doi-asserted-by":"crossref","first-page":"7410","DOI":"10.1074\/jbc.275.10.7410","article-title":"Modulation of beta-amyloid precursor protein processing by the low density lipoprotein receptor-related protein (LRP). Evidence that LRP contributes to the pathogenesis of Alzheimer's disease","volume":"275","author":"Ulery","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2024.102291_bib215","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.isci.2019.05.004","article-title":"Mesenchymal Stromal Cell Homing: Mechanisms and Strategies for Improvement","volume":"15","author":"Ullah","year":"2019","journal-title":"iScience"},{"key":"10.1016\/j.arr.2024.102291_bib216","doi-asserted-by":"crossref","first-page":"10818","DOI":"10.18632\/aging.203026","article-title":"Phyto-nanotechnology in anti-aging medicine","volume":"13","author":"Vaiserman","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.arr.2024.102291_bib217","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.addr.2019.02.007","article-title":"Nanoparticle technology and stem cell therapy team up against neurodegenerative disorders","volume":"148","author":"Vissers","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.arr.2024.102291_bib218","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa1304369","article-title":"Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine","volume":"369","author":"Von Hoff","year":"2013","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.arr.2024.102291_bib219","first-page":"143","article-title":"The blood-brain barrier in neuroinflammatory diseases","volume":"49","author":"de Vries","year":"1997","journal-title":"Pharm. Rev."},{"key":"10.1016\/j.arr.2024.102291_bib220","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1146\/annurev-med-040210-162544","article-title":"Nanoparticle delivery of cancer drugs","volume":"63","author":"Wang","year":"2012","journal-title":"Annu Rev. Med"},{"key":"10.1016\/j.arr.2024.102291_bib221","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.695479","article-title":"Relationship Between Amyloid-\u03b2 Deposition and Blood-Brain Barrier Dysfunction in Alzheimer's Disease","volume":"15","author":"Wang","year":"2021","journal-title":"Front Cell Neurosci."},{"key":"10.1016\/j.arr.2024.102291_bib222","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1039\/D0BM01164A","article-title":"Recent advances in mesenchymal stem cell membrane-coated nanoparticles for enhanced drug delivery","volume":"9","author":"Wang","year":"2021","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.arr.2024.102291_bib223","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/bit.26045","article-title":"Microfluidic blood-brain barrier model provides in vivo-like barrier properties for drug permeability screening","volume":"114","author":"Wang","year":"2017","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.arr.2024.102291_bib224","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.mibio.2003.09.014","article-title":"Determination of lipophilicity and its use as a predictor of blood\u2013brain barrier penetration of molecular imaging agents","volume":"5","author":"Waterhouse","year":"2003","journal-title":"Mol. Imaging Biol."},{"key":"10.1016\/j.arr.2024.102291_bib225","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1080\/10717544.2022.2120566","article-title":"Monoclonal antibody as a targeting mediator for nanoparticle targeted delivery system for lung cancer","volume":"29","author":"Wathoni","year":"2022","journal-title":"Drug Deliv."},{"key":"10.1016\/j.arr.2024.102291_bib226","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3389\/fphar.2017.00020","article-title":"In vivo Evidence for Therapeutic Properties of Cannabidiol (CBD) for Alzheimer's Disease","volume":"8","author":"Watt","year":"2017","journal-title":"Front Pharm."},{"key":"10.1016\/j.arr.2024.102291_bib227","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1042\/BJ20110293","article-title":"Tetrahydrobiopterin: biochemistry and pathophysiology","volume":"438","author":"Werner","year":"2011","journal-title":"Biochem J."},{"key":"10.1016\/j.arr.2024.102291_bib228","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.brainres.2010.08.034","article-title":"ABC efflux transporters in brain vasculature of Alzheimer's subjects","volume":"1358","author":"Wijesuriya","year":"2010","journal-title":"Brain Res"},{"key":"10.1016\/j.arr.2024.102291_bib229","doi-asserted-by":"crossref","DOI":"10.1038\/natrevmats.2016.14","article-title":"Analysis of nanoparticle delivery to tumours","volume":"1","author":"Wilhelm","year":"2016","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.arr.2024.102291_bib230","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1212\/01.wnl.0000281847.17519.e0","article-title":"IDEAL: a 6-month, double-blind, placebo-controlled study of the first skin patch for Alzheimer disease","volume":"69","author":"Winblad","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2024.102291_bib231","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S1537-1891(02)00200-8","article-title":"Tight junctions of the blood-brain barrier: development, composition and regulation","volume":"38","author":"Wolburg","year":"2002","journal-title":"Vasc. Pharm."},{"key":"10.1016\/j.arr.2024.102291_bib232","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00441-008-0658-9","article-title":"Brain endothelial cells and the glio-vascular complex","volume":"335","author":"Wolburg","year":"2009","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.arr.2024.102291_bib233","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41392-023-01481-w","article-title":"The blood-brain barrier: structure, regulation, and drug delivery","volume":"8","author":"Wu","year":"2023","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.arr.2024.102291_bib234","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1016\/j.biomaterials.2010.01.010","article-title":"PET\/NIRF\/MRI triple functional iron oxide nanoparticles","volume":"31","author":"Xie","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.arr.2024.102291_bib235","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2019.119491","article-title":"Nanomaterial-based blood-brain-barrier (BBB) crossing strategies","volume":"224","author":"Xie","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.arr.2024.102291_bib236","doi-asserted-by":"crossref","first-page":"27066","DOI":"10.3402\/jev.v4.27066","article-title":"Biological properties of extracellular vesicles and their physiological functions","volume":"4","author":"Y\u00e1\u00f1ez-M\u00f3","year":"2015","journal-title":"J. Extra Vesicles"},{"key":"10.1016\/j.arr.2024.102291_bib237","doi-asserted-by":"crossref","first-page":"4449","DOI":"10.2147\/IJN.S208332","article-title":"Curcumin-loaded nanoparticles: a novel therapeutic strategy in treatment of central nervous system disorders","volume":"14","author":"Yavarpour-Bali","year":"2019","journal-title":"Int J. Nanomed."},{"key":"10.1016\/j.arr.2024.102291_bib238","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.addr.2020.07.022","article-title":"Recent advances in siRNA delivery mediated by lipid-based nanoparticles","volume":"154-155","author":"Yonezawa","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.arr.2024.102291_bib239","doi-asserted-by":"crossref","first-page":"e698","DOI":"10.1016\/j.wneu.2018.06.114","article-title":"Convection-Enhanced Delivery of Polymeric Nanoparticles Encapsulating Chemotherapy in Canines with Spontaneous Supratentorial Tumors","volume":"117","author":"Young","year":"2018","journal-title":"World Neurosurg."},{"key":"10.1016\/j.arr.2024.102291_bib240","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.7150\/thno.13398","article-title":"Noninvasive Dynamic Imaging of Tumor Early Response to Nanoparticle-mediated Photothermal Therapy","volume":"5","author":"Zhang","year":"2015","journal-title":"Theranostics"},{"key":"10.1016\/j.arr.2024.102291_bib241","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1021\/mp400685v","article-title":"Mechanism study of cellular uptake and tight junction opening mediated by goblet cell-specific trimethyl chitosan nanoparticles","volume":"11","author":"Zhang","year":"2014","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.arr.2024.102291_bib242","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/sj.clpt.6100400","article-title":"Nanoparticles in medicine: therapeutic applications and developments","volume":"83","author":"Zhang","year":"2008","journal-title":"Clin. Pharm. Ther."},{"key":"10.1016\/j.arr.2024.102291_bib243","article-title":"Development of Polymeric Nanoparticles for Blood-Brain Barrier Transfer-Strategies and Challenges","volume":"8","author":"Zhang","year":"2021","journal-title":"Adv. Sci. (Weinh. )"},{"key":"10.1016\/j.arr.2024.102291_bib244","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1124\/jpet.104.068528","article-title":"Plasma membrane localization of multidrug resistance-associated protein homologs in brain capillary endothelial cells","volume":"311","author":"Zhang","year":"2004","journal-title":"J. Pharm. Exp. Ther."},{"key":"10.1016\/j.arr.2024.102291_bib245","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121690","article-title":"Blood-brain barrier Permeable nanoparticles for Alzheimer's disease treatment by selective mitophagy of microglia","volume":"288","author":"Zhong","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.arr.2024.102291_bib246","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.2174\/092986708785132870","article-title":"Substrates and inhibitors of human multidrug resistance associated proteins and the implications in drug development","volume":"15","author":"Zhou","year":"2008","journal-title":"Curr. Med Chem."},{"key":"10.1016\/j.arr.2024.102291_bib247","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1177\/0269881108096519","article-title":"Cannabidiol for the treatment of psychosis in Parkinson's disease","volume":"23","author":"Zuardi","year":"2009","journal-title":"J. Psychopharmacol."}],"container-title":["Ageing Research Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163724001090?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163724001090?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T17:15:03Z","timestamp":1715620503000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568163724001090"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":247,"alternative-id":["S1568163724001090"],"URL":"https:\/\/doi.org\/10.1016\/j.arr.2024.102291","relation":{},"ISSN":["1568-1637"],"issn-type":[{"value":"1568-1637","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treating Alzheimer\u2019s disease using nanoparticle-mediated drug delivery strategies\/systems","name":"articletitle","label":"Article Title"},{"value":"Ageing Research Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arr.2024.102291","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102291"}}